What is Proto Script Pharmaceutical Corp. (PSCR)?

Proto Script Pharmaceutical Corp. (PSCR) is a stock in the Industrials sector, Specialty Business Services industry. View full analysis on Stocks360.

What is the current price of PSCR?

The current price of PSCR is $0.00. Prices are updated in real time on Stocks360.

What is PSCR's price-to-earnings (PE) ratio?

PSCR's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is PSCR's market capitalization?

PSCR's market capitalization is $4,914.00, placing it in the small-cap tier.

Proto Script Pharmaceutical Corp. (PSCR)

Stock analysis · OTC · Industrials · Specialty Business Services

$0.00

Market Cap

$4.91K

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

6.35

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

95.35K

Proto Script Pharmaceutical Corp. (PSCR) is a publicly traded company in the Industrials sector. Latest price: $0.00. Market cap $4.91K. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $0.00 2026-10-29 · $0.00 (-66.67%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Proto Script Pharmaceutical Corp.

Proto Script Pharmaceutical Corp., established in 2001 and headquartered in Rancho Cucamonga, California, specializes in the maintenance and rental of power wheelchairs and scooters. The firm primarily caters to federal, state, and private insurance providers.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	0.01×
P/B	-0.03×
PEG	0.00×
P/FCF (TTM)	0.17×
EV / EBITDA	-0.18×
EV / Sales	0.07×
Earnings Yield	-76483.33%
Free Cash Flow Yield	587.69%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$52.70K
Revenue (TTM)	$788.96K
Net Income (TTM)	-$3.76M
Free Cash Flow (TTM)	$28.88K
Net Debt	$47.78K
Working Capital	-$345.28K
Gross Margin	71.55%
Operating Margin	-37.78%
Net Margin	-910.40%
Return on Equity	5578.94%
Return on Invested Capital	111.04%